These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 3592392

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of a commercially available vaccine against Corynebacterium pseudotuberculosis for use in sheep.
    Piontkowski MD, Shivvers DW.
    J Am Vet Med Assoc; 1998 Jun 01; 212(11):1765-8. PubMed ID: 9621886
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Protection in alpacas against Corynebacterium pseudotuberculosis using different bacterial components.
    Braga WU.
    Vet Microbiol; 2007 Jan 31; 119(2-4):297-303. PubMed ID: 16982160
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunisation against ovine caseous lymphadenitis: comparison of Corynebacterium pseudotuberculosis vaccines with and without bacterial cells.
    Eggleton DG, Middleton HD, Doidge CV, Minty DW.
    Aust Vet J; 1991 Oct 31; 68(10):317-9. PubMed ID: 1755781
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of an ovine caseous lymphadenitis vaccine formulated using a genetically inactive form of the Corynebacterium pseudotuberculosis phospholipase D.
    Hodgson AL, Carter K, Tachedjian M, Krywult J, Corner LA, McColl M, Cameron A.
    Vaccine; 1999 Feb 26; 17(7-8):802-8. PubMed ID: 10067685
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The control of Corynebacterium pseudotuberculosis infection in sheep flocks: a mathematical model of the impact of vaccination, serological testing, clinical examination and lancing of abscesses.
    O'Reilly KM, Medley GF, Green LE.
    Prev Vet Med; 2010 Jun 01; 95(1-2):115-26. PubMed ID: 20304509
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A field trial to evaluate a whole cell vaccine for the prevention of caseous lymphadenitis in sheep and goat flocks.
    Menzies PI, Muckle CA, Brogden KA, Robinson L.
    Can J Vet Res; 1991 Oct 01; 55(4):362-6. PubMed ID: 1790493
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of a toxoid vaccine to protect goats against intradermal challenge exposure to Corynebacterium pseudotuberculosis.
    Brown CC, Olander HJ, Biberstein EL, Morse SM.
    Am J Vet Res; 1986 May 01; 47(5):1116-9. PubMed ID: 3717735
    [Abstract] [Full Text] [Related]

  • 19. Immunisation against ovine caseous lymphadenitis: efficacy of monocomponent Corynebacterium pseudotuberculosis toxoid vaccine and combined clostridial-corynebacterial vaccines.
    Eggleton DG, Doidge CV, Middleton HD, Minty DW.
    Aust Vet J; 1991 Oct 01; 68(10):320-1. PubMed ID: 1755782
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.